"Hurts less, lasts longer"; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand.
Julie CooperStephanie L EnkelDhevindri MoodleyHazel DobinsonErik AndersenJoseph H KadoRenae K BarrSam SalmanMichael G BakerJonathan R CarapetisLaurens ManningAnneka AndersonJulie BennettPublished in: PloS one (2024)
Participants preferred SCIP over their usual regimen, reporting less pain and a preference for the longer time gap between treatments. Recommending SCIP as standard of care for most patients needing long-term prophylaxis has the potential to transform secondary prophylaxis of ARF/RHD in NZ and globally.
Keyphrases
- high dose
- end stage renal disease
- healthcare
- newly diagnosed
- chronic kidney disease
- ejection fraction
- pain management
- chronic pain
- palliative care
- mental health
- peritoneal dialysis
- low dose
- pulmonary hypertension
- stem cell transplantation
- quality improvement
- adverse drug
- neuropathic pain
- patient reported outcomes
- spinal cord
- platelet rich plasma
- affordable care act